PDL BioPharma, Inc. Research and Development Expense of Revenue

Research and Development Expense of Revenue of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Research and Development Expense of Revenue growth rates and interactive chart.


Highlights and Quick Summary

  • Research and Development Expense of Revenue for the quarter ending June 29, 2020 was 28.11% (a -9.21% decrease compared to previous quarter)
  • Year-over-year quarterly Research and Development Expense of Revenue increased by 188.01%
  • Annual Research and Development Expense of Revenue for 2019 was 13.35% (a 795.97% increase from previous year)
  • Annual Research and Development Expense of Revenue for 2018 was 1.49% (a -35.5% decrease from previous year)
  • Annual Research and Development Expense of Revenue for 2017 was 2.31% (a 48.08% increase from previous year)
  • Twelve month Research and Development Expense of Revenue ending June 29, 2020 was 17.05% (a 11.66% increase compared to previous quarter)
  • Twelve month trailing Research and Development Expense of Revenue increased by 155.24% year-over-year
Trailing Research and Development Expense of Revenue for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
17.05% 15.27% 13.35% 6.68%
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Research and Development Expense of Revenue of PDL BioPharma, Inc.

Most recent Research and Development Expense of Revenueof PDLI including historical data for past 10 years.

Interactive Chart of Research and Development Expense of Revenue of PDL BioPharma, Inc.

PDL BioPharma, Inc. Research and Development Expense of Revenue for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 28.11% 30.96%
2019 -33.75% 9.76% 11.88% 13.59% 13.35%
2018 1.79% 0.99% 1.47% 2.06% 1.49%
2017 1.07% 0.96% 2.98% 3.89% 2.31%
2016 2.84% 3.6% 0.0% 0.0% 1.56%
2015 0.0% 0.0% 0.0% 0.0% 0.0%
2014 0.0% 0.0% 0.0% 0.0% 0.0%
2013 0.0% 0.0% 0.0% 0.0% 0.0%
2012 0.0% 0.0% 0.0% 0.0% 0.0%
2011 0.0% 0.0% 0.0% 0.0% 0.0%
2010 0.0% 0.0% 0.0% 0.0%

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.